The research, published in the journal EMBO Molecular Medicine, is a promising development for women with basal-like breast cancer, sometimes known as triple-negative disease.
http://www.sciencedaily.com/releases/2013/04/130423135712.htm?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine%2Fdiseases_and_conditions+%28ScienceDaily%3A+Health+%26+Medicine+News+--+Diseases+and+Conditions%29
http://www.sciencedaily.com/releases/2013/04/130423135712.htm?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine%2Fdiseases_and_conditions+%28ScienceDaily%3A+Health+%26+Medicine+News+--+Diseases+and+Conditions%29
No comments:
Post a Comment